EXACT Sciences Corp. (EXAS)

115.20
1.70 1.50
NASDAQ : Health Technology
Prev Close 116.90
Open 117.00
Day Low/High 114.28 / 117.76
52 Wk Low/High 47.78 / 121.98
Volume 1.24M
Avg Volume 1.54M
Exchange NASDAQ
Shares Outstanding 129.14M
Market Cap 15.02B
EPS -1.40
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory

Exact Sciences Advances Fight Against Colorectal Cancer With Opening Of New Laboratory

Company's total lab processing capacity expected to reach 7 million by end of year

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

Wendy's, Zoetis, New Age Beverages: 'Mad Money' Lightning Round

A roundup of Jim Cramer's thoughts on stocks of interest to Mad Money viewers.

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

Trump's Change of Heart: Cramer's 'Mad Money' Recap (Monday 6/3/19)

By going after friendly trading partners and big tech Trump is forcing Wall Street to re-calibrate and lower valuations, Jim Cramer says.

Exact Sciences To Participate In June Investor Conferences

Exact Sciences To Participate In June Investor Conferences

MADISON, Wis., May 31, 2019 /PRNewswire/ -- Exact Sciences Corp.

Exact Sciences Advances Pipeline Capabilities With Mayo Clinic

Exact Sciences Advances Pipeline Capabilities With Mayo Clinic

Early data on pancreatic cancer detection presented at Digestive Disease Week® 2019

Exact Sciences Presents New Data Reinforcing Performance Of Cologuard®

Exact Sciences Presents New Data Reinforcing Performance Of Cologuard®

Researchers to Present Real-World Findings at Digestive Disease Week® 2019

Noteworthy Friday Option Activity: EXAS, CWH, BCRX

Noteworthy Friday Option Activity: EXAS, CWH, BCRX

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in EXACT Sciences Corp. , where a total volume of 10,929 contracts has been traded thus far today, a contract volume which is representative of approximately 1.1 million underlying shares (given that every 1 contract represents 100 underlying shares).

Exact Sciences To Participate In May Investor Conferences

Exact Sciences To Participate In May Investor Conferences

MADISON, Wis., May 1, 2019 /PRNewswire/ -- Exact Sciences Corp.

First-quarter Revenue And Cologuard Test Volume Increased 79 Percent To $162 Million And 334,000, Respectively

First-quarter Revenue And Cologuard Test Volume Increased 79 Percent To $162 Million And 334,000, Respectively

- Estimated Cologuard market share increased to 4.6 percent during the first quarter

Exact Sciences Schedules First-quarter 2019 Earnings Call

Exact Sciences Schedules First-quarter 2019 Earnings Call

MADISON, Wis., Apr.

Kathleen Sebelius Appointed To Exact Sciences Board

Kathleen Sebelius Appointed To Exact Sciences Board

Former Health and Human Services Secretary brings government and health care expertise to company working to detect cancer earlier

Exact Sciences Looks Vulnerable: Protect Longs

Exact Sciences Looks Vulnerable: Protect Longs

Shares of Exact Sciences has been on the upswing, but the stock price of the cancer screening test firm may be vulnerable.

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

The 6 Stocks To Watch: Cramer's 'Mad Money' Recap (Thursday 3/7/19)

Jim Cramer's watching six stocks to determine when the selling will end.

Exact Sciences Announces Offering Of $600 Million Convertible Senior Notes Due 2027

Exact Sciences Announces Offering Of $600 Million Convertible Senior Notes Due 2027

MADISON, Wis., March 5, 2019 /PRNewswire/ -- Exact Sciences Corporation (NASDAQ: EXAS) (the "Company") today announced an underwritten public offering of $600 million aggregate principal amount of convertible senior notes due 2027 (the "Notes") pursuant...

Exact Sciences To Participate In March Investor Conferences

Exact Sciences To Participate In March Investor Conferences

MADISON, Wis., March 1, 2019 /PRNewswire/ -- Exact Sciences Corp.

Cologuard Helps Screen Two Million People For Colorectal Cancer

Cologuard Helps Screen Two Million People For Colorectal Cancer

Exact Sciences Announces Milestone Ahead of Cologuard Classic, National Colorectal Cancer Awareness Month

Total 2018 Revenue Increased 71 Percent To $454 Million, And 934,000 People Were Screened With Cologuard

Total 2018 Revenue Increased 71 Percent To $454 Million, And 934,000 People Were Screened With Cologuard

- Fourth quarter revenue increased 64 percent to $143.0 million

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

The Earnings Super Bowl: Cramer's 'Mad Money' Recap (Friday 1/25/19)

Jim Cramer's plan for getting through the heart of earnings season next week.

Cronos, Fortinet and Dominion: 'Mad Money' Lightning Round

Cronos, Fortinet and Dominion: 'Mad Money' Lightning Round

Jim Cramer weighs in on Cronos, Fortinet, Dominion Energy and more.

I Am Going to Quote You a Bunch of Statistics Tonight

Some are going to confirm the bearish bias.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: AES, ALIM, APPS, EXAS, INVH, LBRDA, LBRDK, LLY, TLK Downgrades: CTT, DRH, HA, MTDR, ORIT, RNG Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Exact Sciences Stock: Buy at What Level?

Exact Sciences Stock: Buy at What Level?

Our strategy on EXAS shares after the company's latest earnings.

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Costco, Tellurian, Exact Sciences: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Costco, Tellurian, Exact Sciences, XPO Logistics, Align Technology and more.

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Don't Write Off FANG: Cramer's 'Mad Money' Recap (Wednesday 10/31/18)

Jim Cramer says investors need to remember how terrific these companies are, and why they can't be written off.

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Raytheon, Northrop Grumman, Zuora: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Raytheon, Northrop Grumman, Zuora, Exact Sciences.

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

Apple's Trillion-Dollar Market Cap: Cramer's 'Mad Money' Recap (Thur 8/2/18)

This trillion-dollar level is so meaningful, Jim Cramer says, because Apple may be the first company to get here, but it won't be the last. Get ready.

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

EXACT Sciences Corp. Larger Than S&P 500 Component Qorvo

In the latest look at stocks ordered by largest market capitalization, Russell 3000 component EXACT Sciences Corp. was identified as having a larger market cap than the smaller end of the S&P 500, for example Qorvo Inc , according to The Online Investor.

TheStreet Quant Rating: C- (Hold)